Ultralente insulin
Ultralente Insulin
Ultralente insulin (pronounced: ul-tra-len-te in-su-lin) is a type of insulin that is long-acting. It is also known as extended insulin zinc suspension.
Etymology
The term "Ultralente" is derived from the Latin word "ultra", meaning "beyond", and the French word "lente", meaning "slow". This refers to the slow and extended release of insulin into the body.
Description
Ultralente insulin is a crystalline suspension of insulin with a large particle size, which slows down its absorption and extends its duration of action. It is typically injected once or twice daily to provide basal insulin coverage. The onset of action is 4 to 6 hours after injection, with a peak effect at 10 to 16 hours, and a duration of action of up to 24 hours.
Usage
Ultralente insulin is used in the treatment of both Type 1 diabetes and Type 2 diabetes. It is often used in combination with short-acting insulin types to help control blood sugar levels throughout the day.
Related Terms
See Also
External links
- Medical encyclopedia article on Ultralente insulin
- Wikipedia's article - Ultralente insulin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski